The catalytic subunit of DNA-dependent protein kinase regulates proliferation, telomere length, and genomic stability in human somatic cells

Molecular and Cellular Biology

Volumn 28, Issue 20, 2008, Pages 6182-6195

  Ruis, Brian L ^a   Fattah, Kazi R ^a   Hendrickson, Eric A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED DNA;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVE SITE; ENZYME REGULATION; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SOMATIC CELL; TELOMERE;

BIOLOGICAL MARKERS; CATALYTIC DOMAIN; CELL CYCLE; CELL PROLIFERATION; DNA DAMAGE; DNA-ACTIVATED PROTEIN KINASE; ETOPOSIDE; GENE TARGETING; GENOMIC INSTABILITY; HCT116 CELLS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; TELOMERE;

ANIMALIA; MAMMALIA; PRIMATES;

EID: 53549118024     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00355-08     Document Type: Article

References (82)

1. Abdel-Rahman, W. M., K. Katsura, W. Rens, P. A. Gorman, D. Sheer, D. Bicknell, W. F. Bodmer, M. J. Arends, A. H. Wyllie, and P. A. Edwards. 2001. Spectral karyotyping suggests additional subsets of colorectal cancers characterized by pattern of chromosome rearrangement. Proc. Natl. Acad. Sci. USA 98:2538-2543.
2. Allalunis-Turner, J., G. M. Barron, and R. S. Day Day III. 1997. Intact G2-phase checkpoint in cells of a human cell line lacking DNA-dependent protein kinase activity. Radiat. Res. 147:284-287.
3. Allalunis-Turner, M. J., G. M. Barron, R. S. Day III, K. D. Dobler, and R. Mirzayans. 1993. Isolation of two cell lines from a human malignant glioma specimen differing in sensitivity to radiation and chemotherapeutic drugs. Radiat. Res. 134:349-354.
4. Anderson, C. W., and M. J. Allalunis-Turner. 2000. Human TP53 from the malignant glioma-derived cell lines M059J and M059K has a cancer-associated mutation in exon 8. Radiat. Res. 154:473-476.
5. cs, in the DNA repair-defective, human, glioma-derived cell line M059J. Radiat. Res. 156:2-9.
6. Bailey, S. M., M. A. Brenneman, J. Halbrook, J. A. Nickoloff, R. L. Ullrich, and E. H. Goodwin. 2004. The kinase activity of DNA-PK is required to protect mammalian telomeres. DNA Repair 3:225-233.
7. Bertuch, A. A., and V. Lundblad. 2003. The Ku heterodimer performs separable activities at double-strand breaks and chromosome termini. Mol. Cell. Biol. 23:8202-8215.
8. Bogue, M. A., C. Jhappan, and D. B. Roth. 1998. Analysis of variable (diversity) joining recombination in DNA-dependent protein kinase (DNA-PK)-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation. Proc. Natl. Acad. Sci. USA 95:15559-15564.
9. Bosnia, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301:527-530.
10. Buck, D., L. Malivert, R. de Chasseval, A. Barraud, M. C. Fondaneche, O. Sanal, A. Plebani, J. L. Stephan, M. Hufnagel, F. le Deist, A. Fischer, A. Durandy, J. P. de Villartay, and P. Revy. 2006. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124:287-299.
11. Chamberlain, J. R., U. Schwarze, P. R. Wang, R. K. Hirata, K. D. Hanken-son, J. M. Pace, R. A. Underwood, K. M. Song, M. Sussman, P. H. Byers, and D. W. Russell. 2004. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303:1198-1201.
12. Collis, S. J., T. L. DeWeese, P. A. Jeggo, and A. R. Parker. 2005. The life and death of DNA-PK. Oncogene 24:949-961.
13. Darroudi, F., and A. T. Natarajan. 1987. Cytological characterization of Chinese hamster ovary X-ray-sensitive mutant cells xrs 5 and xrs 6.I. Induction of chromosomal aberrations by X-irradiation and its modulation with 3-aminobenzamide and caffeine. Mutat. Res. 177:133-148.
14. cs mutations in dogs and horses: allele frequency and association with neoplasia. Gene 283:263-269.
15. cs and telomerase in telomere length maintenance. EMBO J. 21:6275-6287.
16. cs-deficient mice. EMBO Rep. 5:503-509.
17. Fattah, F. J., N. F. Lichter, K. R. Fattah, S. Oh, and E. A. Hendrickson. 2008. Ku70, an essential gene, modulates the frequency of rAAV-mediated gene targeting in human somatic cells. Proc. Natl. Acad. Sci. USA 105:8703-8708.
18. Fattah, K. R., B. L. Ruis, and E. A. Hendrickson. 2008. Mutations to Ku reveal differences in human somatic cell lines. DNA Repair 7:762-774.
19. Ferreira, M. G., K. M. Miller, and J. P. Cooper. 2004. Indecent exposure: when telomeres become uncapped. Mol. Cell 13:7-18.
20. Finnie, N. J., T. M. Gottlieb, T. Blunt, P. A. Jeggo, and S. P. Jackson. 1995. DNA-dependent protein kinase activity is absent in xrs-6 cells: implications for site-specific recombination and DNA double-strand break repair. Proc. Natl. Acad. Sci. USA 92:320-324.
21. Fujimori, A., R. Araki, R. Fukumura, T. Saito, M. Mori, K. Mita, K. Tatsumi, and M. Abe. 1997. The murine DNA-PKcs gene consists of 86 exons dispersed in more than 250 kb. Genomics 45:194-199.
22. cs gene exhibits aberrant V(D)J recombination not only in the coding joint but also in the signal joint. J. Biol. Chem. 273:13058-13064.
23. cs-null mutation reveals DNA-PK-independent functions for Ku in V(D)J recombination. Immunity 9:367-376.
24. Gao, Y., Y. Sun, K. M. Frank, P. Dikkes, Y. Fujiwara, K. J. Seidl, J. M. Sekiguchi, G. A. Rathbun, W. Swat, J. Wang, R. T. Bronson, B. A. Malynn, M. Bryans, C. Zhu, J. Chaudhuri, L. Davidson, R. Ferrini, T. Stamato, S. H. Orkin, M. E. Greenberg, and F. W. Alt. 1998. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95:891-902.
25. cs is critical for telomere capping. Proc. Natl. Acad. Sci. USA 98:15084-15088.
26. Goytisolo, F. A., E. Samper, S. Edmonson, G. E. Taccioli, and M. A. Blasco. 2001. The absence of the DNA-dependent protein kinase catalytic subunit in mice results in anaphase bridges and in increased telomeric fusions with normal telomere length and G-strand overhang. Mol. Cell. Biol. 21:3642-3651.
27. Gravel, S., M. Larrivee, P. Labrecque, and R. J. Wellinger. 1998. Yeast Ku as a regulator of chromosomal DNA end structure. Science 280:741-744.
28. Han, Z., T. H. Carter, W. H. Reeves, J. H. Wyche, and E. A. Hendrickson. 1996. DNA-dependent protein kinase is a target of a CPP32-like apoptotic protease. J. Biol. Chem. 271:25035-25040.
29. Han, Z., C. Johnston, W. H. Reeves, T. Carter, J. H. Wyche, and E. A. Hendrickson. 1996. Characterization of a Ku86 variant protein that results in altered DNA binding and diminished DNA-dependent protein kinase activity. J. Biol. Chem. 271:14098-14104.
30. Hande, P., P. Slijepcevic, A. Silver, S. Bouffler, P. van Buul, P. Bryant, and P. Lansdorp. 1999. Elongated telomeres in scid mice. Genomics 56:221-223.
31. Hefferin, M. L., and A. E. Tomkinson. 2005. Mechanism of DNA double-strand break repair by non-homologous end joining. DNA Repair 4:639-648.
32. Hendrickson, E. A. 2008. Gene targeting in human somatic cells, p. 509-525. In P. M. Conn (ed.), Source book of models for biomedical research. Humana Press, Inc., Totowa, NJ.
33. Hendrickson, E. A., J. L. Huffman, and J. A. Tainer. 2006. Structural aspects of Ku and the DNA-dependent protein kinase complex, p. 629-684. In W. Seide, Y. W. Kow, and P. Doetsch (ed.), DNA damage recognition. Taylor and Francis Group, New York, NY.
34. Jaco, I., P. Munoz, and M. A. Blasco. 2004. Role of human Ku86 in telomere length maintenance and telomere capping. Cancer Res. 64:7271-7278.
35. cs: a T-cell tumour suppressor encoded at the mouse scid locus. Nat. Genet. 17:483-486.
36. Kim, J. S., H. Crooks, T. Dracheva, T. G. Nishanian, B. Singh, J. Jen, and T. Waldman. 2002. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells. Cancer Res. 62:2744-2748.
37. Kim, J. S., C. Lee, A. Foxworth, and T. Waldman. 2004. B-Raf is dispensable for K-Ras-media ted oncogenesis in human cancer cells. Cancer Res. 64: 1932-1937.
38. Kirchgessner, C. U., C. K. Patil, J. W. Evans, C. A. Cuomo, L. M. Fried, T. Carter, M. A. Oettinger, and J. M. Brown. 1995. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267:1178-1183.
39. Kohli, M., C. Rago, C. Lengauer, K. W. Kinzler, and B. Vogelstein. 2004. Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. Nucleic Acids Res. 32:e3.
40. Lee, S. E., R. A. Mitchell, A. Cheng, and E. A. Hendrickson. 1997. Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol. Cell. Biol. 17:1425-1433.
41. 2/M arrest after DNA damage. Cell 94:399-409.
42. Lee, S. E., C. R. Pulaski, D. M. He, D. M. Benjamin, M. Voss, J. Um, and E. A. Hendrickson. 1995. Isolation of mammalian cell mutants that are X-ray sensitive, impaired in DNA double-strand break repair and defective for V(D)J recombination. Mutat. Res. 336:279-291.
43. Lees-Miller, S. P., R. Godbout, D. W. Chan, M. Weinfeld, R. S. Day III, G. M. Barron, and J. Allalunis-Turner. 1995. Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science 267:1183-1185.
44. Li, G., C. Nelsen, and E. A. Hendrickson. 2002. Ku86 is essential in human somatic cells. Proc. Natl. Acad. Sci. USA 99:832-837.
45. Li, G. C., H. Ouyang, X. Li, H. Nagasawa, J. B. Little, D. J. Chen, C. C. Ling, Z. Fuks, and C. Cordon-Cardo. 1998. Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol. Cell 2:1-8.
46. Li, X., and W. D. Heyer. 2008. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 18:99-113.
47. Lieber, M. R., Y. Ma, Y. Kefei, U. Pannicke, and K. Schwarz. 2006. The mechanism of vertebrate nonhomologous DNA end joining and its role in immune system gene rearrangements, p. 609-627. In W. Seide, Y. W. Kow, and P. Doetsch (ed.). DNA damage recognition. Taylor and Francis Group, New York, NY.
48. Maser, R. S., and R. A. DePinho. 2002. Connecting chromosomes, crisis, and cancer. Science 297:565-569.
49. Masramon, L., M. Ribas, P. Cifuentes, R. Arribas, F. Garcia, J. Egozcue, M. A. Peinado, and R. Miro. 2000. Cytogenetic characterization of two colon cell lines by using conventional G-banding, comparative genomic hybridization, and whole chromosome painting. Cancer Genet. Cytogenet. 121:17-21.
50. McElligott, R., and R. J. Wellinger. 1997. The terminal DNA structure of mammalian chromosomes. EMBO J. 16:3705-3714.
51. McGuire, T. C., and M. J. Poppie. 1973. Hypogammaglobulinemia and thymic hypoplasia in horses: a primary combined immunodeficiency disorder. Infect. Immunol. 8:272-277.
52. Meek, K., S. Gupta, D. A. Ramsden, and S. P. Lees-Miller. 2004. The DNA-dependent protein kinase: the director at the end. Immunol. Rev. 200:132-141.
53. Meek, K., L. Kienker, C. Dallas, W. Wang, M. J. Dark, P. J. Venta, M. L. Huie, R. Hirschhorn, and T. Bell. 2001. SCID in Jack Russell terriers: a new animal model of DNA-PKcs deficiency. J. Immunol. 167:2142-2150.
54. Montecucco, A., and G. Biamonti. 2007. Cellular response to etoposide treatment. Cancer Lett. 252:9-18.
55. Morozov, V. E., M. Falzon, C. W. Anderson, and E. L. Kuff. 1994. DNA-dependent protein kinase is activated by nicks and larger single-stranded gaps. J. Biol. Chem. 269:16684-16688.
56. Moshous, D., I. Callebaut, R. de Chasseval, B. Corneo, M. Cavazzana-Calvo, F. Le Deist, I. Tezcan, O. Sanal, Y. Bertrand, N. Philippe, A. Fischer, and J. P. de Villartay. 2001. Artemis, a novel DNA double-strand break repair/ V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105:177-186.
57. 2 and M phases of the cell cycle. Mol. Cell. Biol. 18:5797-5808.
58. Myung, K., G. Ghosh, F. J. Fattah, G. Li, H. Kim, A. Dutia, E. Pak, S. Smith, and E. A. Hendrickson. 2004. Regulation of telomere length and suppression of genomic instability in human somatic cells by Ku86. Mol. Cell. Biol. 24:5050-5059.
59. Nussenzweig, A., C. Chen, V. da Costa Soares, M. Sanchez, K. Sokol, M. C. Nussenzweig, and G. C. Li. 1996. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature 382:551-555.
60. O'Driscoil, M., K. M. Cerosaletti, P. M. Girard, Y. Dai, M. Stumm, B. Kysela, B. Hirsch, A. Gennery, S. E. Palmer, J. Seidel, R. A. Gatti, R. Varon, M. A. Oettinger, H. Neitzel, P. A. Jeggo, and P. Concannon. 2001. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell 8:1175-1185.
61. Ouyang, H., A. Nussenzweig, A. Kurimasa, V. C. Soares, X. Li, C. CordonCardo, W. Li, N. Cheong, M. Nussenzweig, G. Iliakis, D. J. Chen, and G. C. Li. 1997. Ku70 is required for DNA repair but not for T cell antigen receptor gene recombination in vivo. J. Exp. Med. 186:921-929.
62. Peterson, S. R., A. Kurimasa, M. Oshimura, W. S. Dynan, E. M. Bradbury, and D. J. Chen. 1995. Loss of the 350kD catalytic subunit of the DNA dependent protein kinase in DNA double-strand break repair mutant mammalian cells. Proc. Natl. Acad. Sci. USA 92:3171-3174.
63. Priestley, A., H. J. Beamish, D. Gell, A. G. Amatucci, M. C. Muhlmann-Diaz, B. K. Singleton, G. C. Smith, T. Blunt, L. C. Schalkwyk, J. S. Bedford, S. P. Jackson, P. A. Jeggo, and G. E. Taccioli. 1998. Molecular and biochemical characterisation of DNA-dependent protein kinase-defective rodent mutant irs-20. Nucleic Acids Res. 26:1965-1973.
64. Rathmell, W. K., and G. Chu. 1994. A DNA end-binding factor involved in double-strand break repair and V(D)J recombination. Mol. Cell. Biol. 14: 4741-4748.
65. Riballo, E., S. E. Critchlow, S.-H. Teo, A. J. Doherty, A. Priestley, B. Broughton, B. Kysela, H. Beamish, N. Plowman, C. F. Arlett, A. R. Lehmann, S. J. Jackson, and P. A. Jeggo. 1999. Identification of a defect in DNA ligase IV in a radiosensitive leukemia patient. Curr. Biol. 9:699-702.
66. Riha, K., and D. E. Shippen. 2003. Ku is required for telomeric C-rich strand maintenance but not for end-to-end chromosome fusions in Arabidopsis. Proc. Natl. Acad. Sci. USA 100:611-615.
67. Sekiguchi, J. M., and D. O. Ferguson. 2006. DNA double-strand break repair: a relentless hunt uncovers new prey. Cell 124:260-262.
68. Shima, N., A. Alcaraz, I. Liachko, T. R. Buske, C. A. Andrews, R. J. Munroe, S. A. Hartford, B. K. Tye, and J. C. Schimenti. 2007. A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nat. Genet. 39:93-98.
69. cs in equine SCID results in defective coding and signal joint formation. J. Immunol. 158:3565-3569.
70. Shirasawa, S., M. Furuse, N. Yokoyama, and T. Sasazuki. 1993. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260:85-88.
71. Soulas-Sprauel, P., P. Rivera-Munoz, L. Malivert, G. Le Guyader, V. Abramowski, P. Revy, and J. P. de Villartay. 2007. V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining. Oncogene 26:7780-7791.
72. Taccioli, G. E., A. G. Amatucci, H. J. Beamish, D. Gell, X. H. Xiang, M. I. Torres Arzayus, A. Priestley, S. P. Jackson, A. Marshak Rothstein, P. A. Jeggo, and V. L. Herrera. 1998. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity 9:355-366.
73. Takai, H., R. C. Wang, K. K. Takai, H. Yang, and T. de Lange. 2007. Tel2 regulates the stability of PI3K-related protein kinases. Cell 131:1248-1259.
74. Tsuchida, R., T. Yamada, M. Takagi, A. Shimada, C. Ishioka, Y. Katsuki, T. Igarashi, L. Chessa, D. Delia, H. Teraoka, and S. Mizutani. 2002. Detection of ATM gene mutation in human glioma cell line M059J by a rapid frame-shift/stop codon assay in yeast. Radiat. Res. 158:195-201.
75. Uegaki, K., N. Adachi, S. So, S. Iiizumi, and H. Koyama. 2006. Heterozygous inactivation of human Ku70/Ku86 heterodimer does not affect cell growth, double-strand break repair, or genome integrity. DNA Repair 5:303-311.
76. van Steensel, B., A. Smogorzewska, and T. de Lange. 1998. TRF2 protects human telomeres from end-to-end fusions. Cell 92:401-413.
77. van Veelen, L., J. Wesoly, and R. Kanaar. 2006. Biochemical and cellular aspects of homologous recombination, p. 581-607. In W. Seide, Y. W. Kow, and P. Doetsch (ed.), DNA damage recognition. Taylor and Francis Group, New York, NY.
78. Vasileva, A., and R. Jessberger. 2005. Precise hit: adeno-associated virus in gene targeting. Nat. Rev. Microbiol. 3:837-847.
79. Wiler, R., R. Leber, B. B. Moore, L. F. VanDyk, L. E. Perryman, and K. Meek. 1995. Equine severe combined immunodeficiency: a defect in V(D)J recombination and DNA-dependent protein kinase activity. Proc. Natl. Acad. Sci. USA 92:11485-11489.
80. Woods, T., W. Wang, E. Convery, A. Errami, M. Z. Zdzienicka, and K. Meek. 2002. A single amino acid substitution in DNA-PKcs explains the novel phenotype of the CHO mutant, XR-C2. Nucleic Acids Res. 30:5120-5128.
81. Zdzienicka, M. Z. 1999. Mammalian X-ray-sensitive mutants which are defective in non-homologous (illegitimate) DNA double-strand break repair. Biochimie 81:107-116.
82. Zhu, C., M. A. Bogue, D. S. Lim, P. Hasty, and D. B. Roth. 1996. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell 86:379-389.